7th Digital Pharma West

Why 7th Digital Pharma West Is the Number One Provider of Content, Innovation and Practical Insights on the West Coast.

Pharmaceutical and medical device companies of ALL sizes and scales need to understand how pharma can ensure that digital is part of their company's DNA. It's not just about doing better digital marketing, it's about embedding digital into everything you do across divisions — from the earliest R&D to postmarketing/commercial. It's about how you communicate and collaborate across "yourselves" and even how you find and recruit talent to improve your business.

Delivering better outcomes through innovative digital initiatives with patient co-creation at the heart. Together as an industry, we can build a business that will:

• Put patients first
• Think patient
• Empower the empowered patient
• Truly get why patients matter
• Understand why patients are at the center of what we do
• Deliver the patient experience
• Go beyond the patient — people
• Recognize that people are at the heart of every patient

Who is your customer in 2016? In previous years it was "all about the HCP." Physicians continue to be the major goal in engagement, education and access. Additionally, the growth of pharmacies as a venue of health management is a dynamic shift. Pharmacies are shifting to become health delivery agents for the patients, and the patient journey/experience engenders many objectives and questions that pharma must consider. All of this means there are challenges and questions that need answering, but where do we start?

• The innovation landscape today: What can we do to solve current business challenges with innovation, and how can we incorporate innovation teams with marketing, IT, regulatory, and even R&D?
•The need for an overarching, global consumer engagement strategy: What is the level of innovation needed and how can we differentiate with offerings, not just price?
• The gap between “pharma speed” and “digital speed”: How and what can we leverage from other sectors to help us bridge the gap?
• Whether pharma can move past the absence of a “fail fast” mentality: Can pharma adopt a company culture that is less risk averse and lends itself to improved operational efficiency to allow for more innovative tools and offerings?
• Pharmacy engagement: How can we establish pharmacy engagement as a growing part of the value chain?